Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Multipoint targeting of the PI3K/mTOR pathway in mesothelioma.

Zhou S, Liu L, Li H, Eilers G, Kuang Y, Shi S, Yan Z, Li X, Corson JM, Meng F, Zhou H, Sheng Q, Fletcher JA, Ou WB.

Br J Cancer. 2014 May 13;110(10):2479-88. doi: 10.1038/bjc.2014.220. Epub 2014 Apr 24.

2.

The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura.

Chirieac LR, Pinkus GS, Pinkus JL, Godleski J, Sugarbaker DJ, Corson JM.

Am J Cancer Res. 2011;1(1):14-24. Epub 2010 Sep 30.

3.

The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas.

Churg A, Cagle P, Colby TV, Corson JM, Gibbs AR, Hammar S, Ordonez N, Roggli VL, Tazelaar HD, Travis WD, Wick M; US-Canadian Mesothelioma Reference Panel.

Am J Surg Pathol. 2011 Dec;35(12):1823-9. doi: 10.1097/PAS.0b013e31822a2481.

PMID:
21959310
4.

Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.

Ou WB, Hubert C, Corson JM, Bueno R, Flynn DL, Sugarbaker DJ, Fletcher JA.

Neoplasia. 2011 Jan;13(1):12-22.

5.

AXL regulates mesothelioma proliferation and invasiveness.

Ou WB, Corson JM, Flynn DL, Lu WP, Wise SC, Bueno R, Sugarbaker DJ, Fletcher JA.

Oncogene. 2011 Apr 7;30(14):1643-52. doi: 10.1038/onc.2010.555. Epub 2010 Dec 6.

PMID:
21132014
6.

Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.

Richards WG, Godleski JJ, Yeap BY, Corson JM, Chirieac LR, Zellos L, Mujoomdar A, Jaklitsch MT, Bueno R, Sugarbaker DJ.

Cancer. 2010 Mar 15;116(6):1510-7. doi: 10.1002/cncr.24886. Erratum in: Cancer. 2010 May 15;116(10):2503.

7.

Pathologic evaluation of malignant pleural mesothelioma.

Chirieac LR, Corson JM.

Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):121-4. doi: 10.1053/j.semtcvs.2009.06.005. Review.

PMID:
19822283
8.

Localized malignant mesothelioma.

Allen TC, Cagle PT, Churg AM, Colby TV, Gibbs AR, Hammar SP, Corson JM, Grimes MM, Ordonez NG, Roggli V, Travis WD, Wick MR.

Am J Surg Pathol. 2005 Jul;29(7):866-73.

PMID:
15958850
9.

Pathology of mesothelioma.

Corson JM.

Thorac Surg Clin. 2004 Nov;14(4):447-60. Review.

PMID:
15559051
10.

Lysophosphatidic acid inhibition of the accumulation of Pseudomonas aeruginosa PAO1 alginate, pyoverdin, elastase and LasA.

Laux DC, Corson JM, Givskov M, Hentzer M, Møller A, Wosencroft KA, Olson JC, Krogfelt KA, Goldberg JB, Cohen PS.

Microbiology. 2002 Jun;148(Pt 6):1709-23.

PMID:
12055291
11.

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM Jr, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ.

J Thorac Cardiovasc Surg. 1999 Jan;117(1):54-63; discussion 63-5.

12.

Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.

Samuels BL, Herndon JE 2nd, Harmon DC, Carey R, Aisner J, Corson JM, Suzuki Y, Green MR, Vogelzang NJ.

Cancer. 1998 Apr 15;82(8):1578-84.

PMID:
9554537
13.

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.

Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ.

Chest. 1998 Mar;113(3):723-31.

PMID:
9515850
14.

Pathology of diffuse malignant pleural mesothelioma.

Corson JM.

Semin Thorac Cardiovasc Surg. 1997 Oct;9(4):347-55. Review.

PMID:
9352951
15.

Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.

Yogelzang NJ, Herndon JE 2nd, Cirrincione C, Harmon DC, Antman KH, Corson JM, Suzuki Y, Citron ML, Green MR.

Cancer. 1997 Jun 1;79(11):2237-42.

PMID:
9179072
16.

1H-NMR detectable fatty acyl chain unsaturation in excised leiomyosarcoma correlate with grade and mitotic activity.

Singer S, Sivaraja M, Souza K, Millis K, Corson JM.

J Clin Invest. 1996 Jul 15;98(2):244-50.

17.

Malignant mesothelioma following treatment for Hodgkin's disease.

Weissmann LB, Corson JM, Neugut AI, Antman KH.

J Clin Oncol. 1996 Jul;14(7):2098-100.

PMID:
8683242
18.

Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival.

Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM.

J Clin Oncol. 1996 Apr;14(4):1201-8.

PMID:
8648375
19.

Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22.

Naeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA.

Am J Pathol. 1995 Dec;147(6):1553-8.

20.

Detection of chromosome 18 rearrangement in synovial sarcoma by fluorescence in situ hybridization.

Poteat HT, Corson JM, Fletcher JA.

Cancer Genet Cytogenet. 1995 Oct 1;84(1):76-81.

PMID:
7497448
21.

Codeletion of p15 and p16 in primary malignant mesothelioma.

Xio S, Li D, Vijg J, Sugarbaker DJ, Corson JM, Fletcher JA.

Oncogene. 1995 Aug 3;11(3):511-5.

PMID:
7630635
22.

Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma.

Xiao S, Li D, Corson JM, Vijg J, Fletcher JA.

Cancer Res. 1995 Jul 15;55(14):2968-71.

23.

Chromosome aberrations in desmoid tumors. Trisomy 8 may be a predictor of recurrence.

Fletcher JA, Naeem R, Xiao S, Corson JM.

Cancer Genet Cytogenet. 1995 Feb;79(2):139-43.

PMID:
7889507
24.

Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.

Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ.

Ann Surg. 1995 Feb;221(2):185-95.

25.

Trimetrexate in malignant mesothelioma: A Cancer and Leukemia Group B Phase II study.

Vogelzang NJ, Weissman LB, Herndon JE 2nd, Antman KH, Cooper MR, Corson JM, Green MR.

J Clin Oncol. 1994 Jul;12(7):1436-42.

PMID:
8021735
26.

Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.

Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ.

Ann Surg. 1994 Feb;219(2):165-73.

27.

Cardiac synovial sarcoma with translocation (X;18) associated with asbestos exposure.

Karn CM, Socinski MA, Fletcher JA, Corson JM, Craighead JE.

Cancer. 1994 Jan 1;73(1):74-8.

PMID:
8275440
28.

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.

Chahinian AP, Antman K, Goutsou M, Corson JM, Suzuki Y, Modeas C, Herndon JE 2nd, Aisner J, Ellison RR, Leone L, et al.

J Clin Oncol. 1993 Aug;11(8):1559-65.

PMID:
8336195
29.

Synovitis of the knee in a 42-year-old man.

Gravallese EM, Weissman BN, Corson JM, Greene JM.

Arthritis Rheum. 1993 Jun;36(6):860-70. No abstract available.

PMID:
8507229
30.

Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.

Sugarbaker DJ, Strauss GM, Lynch TJ, Richards W, Mentzer SJ, Lee TH, Corson JM, Antman KH.

J Clin Oncol. 1993 Jun;11(6):1172-8.

PMID:
8501504
31.

Selected benefits of thoracotomy and chemotherapy for sarcoma metastatic to the lung.

Mentzer SJ, Antman KH, Attinger C, Shemin R, Corson JM, Sugarbaker DJ.

J Surg Oncol. 1993 May;53(1):54-9.

PMID:
8479198
32.

Fluorescent in situ hybridization assessment of chromosome 7 copy number in uncultured lung and kidney cells.

Naeem R, Donovan K, Corson JM, Fletcher JA.

Cancer Genet Cytogenet. 1993 Apr;66(2):100-2.

PMID:
8500094
33.

Incorporation of immunostaining data in anatomic pathology reports.

Banks PM, Battifora H, Corson JM, LiVolsi V.

Am J Clin Pathol. 1993 Jan;99(1):7. No abstract available.

PMID:
7678482
34.

Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis.

Kay J, Benson CB, Lester S, Corson JM, Pinkus GS, Lazarus JM, Owen WF Jr.

Arthritis Rheum. 1992 Aug;35(8):926-32.

PMID:
1642657
35.

Long-term salvageability for patients with locally recurrent soft-tissue sarcomas.

Singer S, Antman K, Corson JM, Eberlein TJ.

Arch Surg. 1992 May;127(5):548-53; discussion 553-4.

PMID:
1575625
36.

Standardization of the surgical pathology report.

Rosai J, Bonfiglio TA, Corson JM, Fechner RE, Harris NL, LiVolsi VA, Silverberg SG.

Mod Pathol. 1992 Mar;5(2):197-9. No abstract available.

PMID:
1574498
37.

Radiographic detection of metal-induced synovitis as a complication of arthroplasty of the knee.

Weissman BN, Scott RD, Brick GW, Corson JM.

J Bone Joint Surg Am. 1991 Aug;73(7):1002-7.

PMID:
1874762
38.

Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.

Sugarbaker DJ, Heher EC, Lee TH, Couper G, Mentzer S, Corson JM, Collins JJ Jr, Shemin R, Pugatch R, Weissman L, et al.

J Thorac Cardiovasc Surg. 1991 Jul;102(1):10-4; discussion 14-5.

PMID:
2072707
39.

Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel.

McCaughey WT, Colby TV, Battifora H, Churg A, Corson JM, Greenberg SD, Grimes MM, Hammar S, Roggli VL, Unni KK.

Mod Pathol. 1991 May;4(3):342-53.

PMID:
2068061
40.

Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors.

Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, Pinkus GS, Morton CC, Corson JM.

N Engl J Med. 1991 Feb 14;324(7):436-42.

41.

Cytogenetic evidence of clonality in a case of pigmented villonodular synovitis.

Ray RA, Morton CC, Lipinski KK, Corson JM, Fletcher JA.

Cancer. 1991 Jan 1;67(1):121-5.

PMID:
1985707
42.

Melanoma and soft tissue sarcoma in seven patients.

Garber JE, Liepman MK, Gelles EJ, Corson JM, Antman KH.

Cancer. 1990 Dec 1;66(11):2432-4.

PMID:
2245401
43.

Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.

Owen WF Jr, Petersen J, Sheff DM, Folkerth RD, Anderson RJ, Corson JM, Sheffer AL, Austen KF.

Proc Natl Acad Sci U S A. 1990 Nov;87(21):8647-51.

44.

Laboratory investigation and genetics in sarcomas.

Fletcher JA, Weidner N, Corson JM.

Curr Opin Oncol. 1990 Jun;2(3):467-73. Review. No abstract available.

PMID:
1965486
46.

Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B.

Vogelzang NJ, Goutsou M, Corson JM, Suzuki Y, Graziano S, Aisner J, Cooper MR, Coughlin KM, Green MR.

Cancer Chemother Pharmacol. 1990;27(3):239-42.

PMID:
2265461
47.

Rheumatoid aortitis: a rarely recognized but clinically significant entity.

Gravallese EM, Corson JM, Coblyn JS, Pinkus GS, Weinblatt ME.

Medicine (Baltimore). 1989 Mar;68(2):95-106.

PMID:
2921941
48.
49.
50.

Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma.

Turc-Carel C, Dal Cin P, Limon J, Rao U, Li FP, Corson JM, Zimmerman R, Parry DM, Cowan JM, Sandberg AA.

Proc Natl Acad Sci U S A. 1987 Apr;84(7):1981-5.

Supplemental Content

Loading ...
Support Center